NCI Experimental Therapeutics Program (NExT)

The NExT Program supports promising new drug discovery projects through the Chemical Biology Consortium, and small molecule and biologic drug development.

NExT is seeking applications for innovative and promising therapeutic modalities for new oncology targets in cancer therapy.  Applications for treatment approaches and target that are well documented are still encouraged to apply, however, preference to targets with unmet need and rare tumor indications are given priority.

The NExT application submission cycles occur on an ad hoc basis, with the application submissions done using Proposal Central (registration required).

The application cycle submission deadline is 5:00 PM Eastern Time on the close date, even when the close date is on a weekend or holiday.